
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
We are a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTACTM gene targeted chimera small molecules. The companys GeneTACTM molecules are designed to either dial up or dial down the expression of a specific disease-causing gene to address the underlying cause of disease. Designs lead program is focused on the treatment of Friedreich ataxia, followed by programs in Fuchs endothelial corneal dystrophy and myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions. For more information, please visit designtx.com
Design therapeutics operates in the Biotechnology research industry.
Design therapeutics's revenue is 11m - 100m
Design therapeutics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.